Skip to main content
Top
Published in: Clinical Rheumatology 1/2004

01-02-2004 | Case Report

The autoimmune lymphoproliferative syndrome (Canale–Smith) in adulthood

Authors: M. Deutsch, E. Tsopanou, S. P. Dourakis

Published in: Clinical Rheumatology | Issue 1/2004

Login to get access

Abstract

The autoimmune lymphoproliferative syndrome (ALPS) or Canale–Smith syndrome is a recently described clinical entity consisting of chronic, non-malignant lymphadenopathy and hepatosplenomegaly together with hypergammaglobulinemia, positive autoantibodies and/or overt autoimmune diseases. It is caused by a genetic defect in the mechanism of programmed cell death (apoptosis) and is characterized by the presence of double-negative (TCR α/β CD4− CD8−) T lymphocytes (DNT). Although well known in pediatric patients, ALPS is an unusual diagnosis in adults. The oldest reported patient was aged 54. We describe another two adult patients in whom a presenting autoimmune disease led to the diagnosis of ALPS.
Literature
1.
go back to reference Straus SE, Sneller M, Lenardo MJ, Puck J, Strober W (1999) An inherited disorder of lymphocyte apoptosis: The autoimmune lymphoproliferative syndrome. Ann Intern Med 130:591–601PubMed Straus SE, Sneller M, Lenardo MJ, Puck J, Strober W (1999) An inherited disorder of lymphocyte apoptosis: The autoimmune lymphoproliferative syndrome. Ann Intern Med 130:591–601PubMed
2.
go back to reference Drappa J, Vaishaw AK, Sullivan KE, Chu JL, Elkon KB (1996) Fas gene mutations in the Canale–Smith syndrome an inherited lymphoproliferative disorder associated with autoimmunity. N Engl J Med 335:1643–1649PubMed Drappa J, Vaishaw AK, Sullivan KE, Chu JL, Elkon KB (1996) Fas gene mutations in the Canale–Smith syndrome an inherited lymphoproliferative disorder associated with autoimmunity. N Engl J Med 335:1643–1649PubMed
3.
go back to reference Sneller MC, Straus SE, Jaffe ES et al. (1992) A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease. J Clin Invest 90:334–341PubMed Sneller MC, Straus SE, Jaffe ES et al. (1992) A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease. J Clin Invest 90:334–341PubMed
4.
go back to reference Straus SE, Jaffe ES, Puck JM et al. (2001) The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood 98:194–200CrossRefPubMed Straus SE, Jaffe ES, Puck JM et al. (2001) The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood 98:194–200CrossRefPubMed
5.
go back to reference Jackson CE, Puck JM (1999) Autoimmune lymphoproliferative syndrome, a disorder of apoptosis. Curr Opin Pediatr 11:521–527 Jackson CE, Puck JM (1999) Autoimmune lymphoproliferative syndrome, a disorder of apoptosis. Curr Opin Pediatr 11:521–527
6.
go back to reference Rieux Laucat F, Blachere S, Danielan S et al. (1999) Lymphoproliferative syndrome with autoimmunity: a possible genetic basis for dominant expression of the clinical manifestations. Blood 94:2575–2582PubMed Rieux Laucat F, Blachere S, Danielan S et al. (1999) Lymphoproliferative syndrome with autoimmunity: a possible genetic basis for dominant expression of the clinical manifestations. Blood 94:2575–2582PubMed
7.
go back to reference Infante AJ, Britton HA, DeNapoliu T et al. (1998) The clinical spectrum in large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis. J Pediatr 133:629–633PubMed Infante AJ, Britton HA, DeNapoliu T et al. (1998) The clinical spectrum in large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis. J Pediatr 133:629–633PubMed
8.
go back to reference Straus SE, Jaffe ES, Puck JM et al. (2001) The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood 98:194–200CrossRefPubMed Straus SE, Jaffe ES, Puck JM et al. (2001) The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood 98:194–200CrossRefPubMed
9.
go back to reference Gronbaek K, Straten PT, Ralfkiaer E et al. (1998) Somatic Fas mutations in non-Hodgkin’s lymphoma: association with extranodal disease and autoimmuníty. Blood 92:3018–3024PubMed Gronbaek K, Straten PT, Ralfkiaer E et al. (1998) Somatic Fas mutations in non-Hodgkin’s lymphoma: association with extranodal disease and autoimmuníty. Blood 92:3018–3024PubMed
Metadata
Title
The autoimmune lymphoproliferative syndrome (Canale–Smith) in adulthood
Authors
M. Deutsch
E. Tsopanou
S. P. Dourakis
Publication date
01-02-2004
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 1/2004
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-003-0830-2

Other articles of this Issue 1/2004

Clinical Rheumatology 1/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.